Previous Close | 106.78 |
1-Year Change | 30.68% |
6-Months Change | 18.11% |
3-Months Change | 17.66% |
Moving Avg (50d) | 103.73 |
Moving Avg (200d) | 96.52 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 5.29B |
Beta (3-Years) | 0.98 |
Revenue Growth (ttm) | 9.15% |
Net Profit Margin (ttm) | 7.83% |
Return On Assets (ttm) | 2.35% |
EPS (ttm) | 5.53 |
PE Ratio (ttm) | 19.31 |
Dividend Yield | 0.06% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company, publicly traded on the NYSE. With its headquarters in San Ramon, California, it has a workforce of more than 12,000 employees worldwide and consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical which manufactures medical devices and fertility and genomic products... Wikipedia